发明名称 |
PYRIDOPYRIMIDINE OR NAPHTHYRIDINE DERIVATIVE |
摘要 |
The present invention is directed to a pyridopyrimidine or a naphthyridine derivative of the formula (I): (see formula I) wherein R1 is an optionally substituted nitrogen-containing heterocyclic group, an optionally substituted amino group or an optionally substituted alkoxy group; R2 is a hydrogen atom or a lower alkyl group; R3 is a hydrogen atom, an optionally substituted lower alkyl group or an optionally substituted heteroaryl group; R4 is a hydrogen atom, a lower alkyl group, or an optionally esterified or amidated carboxyl group; R5 is a lower alkyl group which may be optionally substituted by a group selected from an optionally substituted aryl group, an optionally substituted heteroaryl group and a di-lower alkylamino group; and one of X and Y is a group of the formula: =CH- and the other is nitrogen atom, or X and Y are both nitrogen atoms, or a pharmaceutically acceptable salt thereof. These compounds exhibit excellent P DEV inhibitory activities, and are useful in the prophylaxis or treatment of penile erectile dysfunction and other functional disorders of cGMP-signaling.
|
申请公布号 |
CA2438294(C) |
申请公布日期 |
2008.10.21 |
申请号 |
CA20022438294 |
申请日期 |
2002.02.25 |
申请人 |
TANABE SEIYAKU CO., LTD. |
发明人 |
OMORI, KENJI;KIKKAWA, KOHEI;YAMADA, KOICHIRO;KOGA, YUICHI;HIKOTA, MASATAKA |
分类号 |
C07D471/04;A61K31/4375;A61K31/519;A61K31/5375;A61P3/10;A61P9/12;A61P11/00;A61P13/12;A61P15/10;A61P43/00;C07D519/00 |
主分类号 |
C07D471/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|